ArticleClinical cancer research : an official journal of the American Association for Cancer Research2016
Correction: MEK plus PI3K/mTORC1/2 Therapeutic Efficacy Is Impacted by TP53 Mutation in Preclinical Models of Colorectal Cancer.
No numbers read from the abstract.
1 paper cites it
this papercites it